Multicenter Contraceptive Efficacy Trial of Injectable Testosterone Undecanoate in Chinese Men
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Context: Hormonal male contraceptive regimens effectively and reversibly suppress sperm production, but there are few large-scale efficacy studies. Objective: The safety, contraceptive efficacy, reversibility, and feasibility of injectable testosterone undecanoate (TU) in tea seed oil as a hormonal male contraceptive was assessed. Design: This was a multicenter, phase III, contraceptive efficacy clinical trial. Participants: A total of 1045 healthy fertile Chinese men were recruited throughout China into the study. Intervention(s): Injections of 500 mg TU were administered monthly for 30 months. A definition of severe oligozoospermia (≤1 × 106/ml) was used as a criterion of spermatogenic suppression and as the threshold for entering the contraceptive efficacy phase. Main Outcome Measure(s): The primary outcome was pregnancy rate in the partner. Other outcomes include: semen parameters, testis volumes, reproductive hormone levels, and safety laboratory tests. Results: Forty-three participants (4.8%) did not achieve azoospermia or severe oligozoospermia within the 6-month suppression phase. A total of 855 participants entered into the efficacy phase, and 733 participants completed monthly TU treatment and follow-up. There were nine pregnancies in 1554.1 person-years of exposure in the 24-month efficacy phase for a cumulative contraceptive failure rate of 1.1 per 100 men. The combined method failure rate was 6.1%, comprising 4.8% with inadequate suppression and 1.3% with postsuppression sperm rebound. No serious adverse events were reported. Spermatogenesis returned to the normal fertile reference range in all but two participants. Conclusions: Monthly injection of 500 mg TU provides safe, effective, reversible, and reliable contraception in a high proportion of healthy fertile Chinese men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contraceptive failure in the United States
Trussell, J. (2011) · Contraception · doi:10.1016/j.contraception.2011.01.021 · Cited by 1,588
Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4163 · Cited by 559
Estimates of contraceptive failure from the 2002 National Survey of Family Growth
Kost, K., Singh, S., Vaughan, B., Trussell, J., & Bankole, A. (2008) · Contraception · doi:10.1016/j.contraception.2007.09.013 · Cited by 444
Contraceptive efficacy of testosterone-induced azoospermia in normal men
(1990) · The Lancet · doi:10.1016/0140-6736(90)92416-f · Cited by 428
Contraceptive failure in the United States
Trussell, J. (2004) · Contraception · doi:10.1016/j.contraception.2004.03.009 · Cited by 420
Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men
World Health Organization Task Force on Methods for the Regulation of Male Fertility (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58221-1 · Cited by 405
Liu, P. Y., Swerdloff, R. S., Christenson, P. D., Handelsman, D. J., & Wang, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68614-5 · Cited by 272 · cited 1×
“Duration of treatment and use of long-acting T esters have been reported to contribute to the rate of recovery of spermatogenesis in an integrated study of all previously reported male contraceptive studies (27).”
Contraceptive efficacy of testosterone‐induced azoospermia in normal men
Zhang, G., Li, G., Wu, F., Baker, H., Wang, X., Soufir, J., Huhtaniemi, I., Paulsen, C., Gottlieb, C., Handelsman, D., et al. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90685-x · Cited by 245
Self-citationGu, Y.-Q., Wang, X.-H., Xu, D., Peng, L., Cheng, L.-F., Huang, M.-K., Huang, Z.-J., & Zhang, G.-Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020447 · Cited by 212 · cited 6×
“As in a previous clinical trial in Chinese men (12), some parameters such as total testis volume and hemoglobin levels did not return to baseline values by the end of the study, although serum hormones had returned to pretreatment levels.”
BackgroundResultInfluentialSelf-citationContraceptive Efficacy of a Depot Progestin and Androgen Combination in Men
Turner, L., Conway, A. J., Jimenez, M., Liu, P. Y., Forbes, E., McLachlan, R. I., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030107 · Cited by 190
Cited by
Eisenberg, M. L., Esteves, S. C., Lamb, D. J., Hotaling, J. M., Giwercman, A., Hwang, K., & Cheng, Y.-S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00459-w · Cited by 536
Testosterone replacement therapy and cardiovascular risk
Gagliano-Jucá, T., & Basaria, S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0211-4 · Cited by 196
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
“Suppression of spermatogenesis Testosterone treatment will suppress gonadotropins and spermatogenesis (109, 110).”
BackgroundPope, H. G., Amiaz, R., Brennan, B. P., Orr, G., Weiser, M., Kelly, J. F., Kanayama, G., Siegel, A., Hudson, J. I., & Seidman, S. N. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d207ca · Cited by 90
The treatment of hypogonadism in men of reproductive age
Kim, E. D., Crosnoe, L., Bar-Chama, N., Khera, M., & Lipshultz, L. I. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.10.052 · Cited by 89
Steroid hormones for contraception in men
Grimes, D. A., Lopez, L. M., Gallo, M. F., Halpern, V., Nanda, K., & Schulz, K. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004316.pub4 · Cited by 55
Metadata
- Authors
- Gu, Y., Liang, X., Wu, W., Liu, M., Song, S., Cheng, L., Bo, L., Xiong, C., Wang, X., Liu, X., Peng, L., & Yao, K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-06-01
- Volume
- 94
- Issue
- 6
- Pages
- 1910-1915
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004474660
- Cited by
- 233
- References
- 28
- FWCI
- 16.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.